Novel insights into the biology and treatment of chronic myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Novel insights into the biology and treatment of chronic myeloproliferative neoplasms

Published:2014-11-19 Issue:7 Volume:56 Page:1938-1948
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mughal Tariq I.,Barbui Tiziano,Abdel-Wahab Omar,Kralovics Robert,Jamieson Catriona,Kvasnicka Hans-Michael,Mullaly Ann,Rampal Raajit,Mesa Ruben,Kiladjian Jean-Jacques,Deininger Michael,Prchal Josef,Hehlmann Rüdiger,Saglio Giuseppe,Van Etten Richard A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.974594

Reference63 articles.

1. Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms

2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

3. ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes

4. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins;Cancers;2024-01-11

2. Mechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms;Hematology/Oncology Clinics of North America;2017-08

3. Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay;Current Drug Targets;2017-02-06

4. CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis;Blood;2017-01-19

5. Chronic myeloid leukemia: reminiscences and dreams;Haematologica;2016-04-30